发明名称 Quinazoline derivatives as Src tyrosine kinase inhibitors
摘要 The invention concerns quinazoline derivatives of Formula (I): (A chemical formula should be inserted here-please see paper copy enclosed herewith) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)2 group wherein each R2 group is hydrogen or (1-8C) alkyl, m is 0, 1, 2 or 3, each R1 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, n is 0, 1, 2 or 3, and each R3 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, or pharmaceutically-acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumor disease.
申请公布号 AU2003278383(B2) 申请公布日期 2007.06.14
申请号 AU20030278383 申请日期 2003.10.29
申请人 ASTRAZENECA AB 发明人 PATRICK PLE
分类号 C07D491/04;A61K31/517;A61P35/00;C07D519/00 主分类号 C07D491/04
代理机构 代理人
主权项
地址
您可能感兴趣的专利